Cited by 265Cellular Mechanics and InteractionsLiver physiology and pathologyElasticity and Material Modeling

Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver

Open access
Fan, Weiguo, Adebowale, Kolade, Váncza, Lóránd, Li, Yuan, Rabbi, Md Foysal, Kunimoto, Koshi, Chen, Dongning, Mozes, Gergely +19 more·2024·Nature

Published version of a preprint

Abstract

Type 2 diabetes mellitus is a major risk factor for hepatocellular carcinoma (HCC). Changes in extracellular matrix (ECM) mechanics contribute to cancer development 1,2 , and increased stiffness is known to promote HCC progression in cirrhotic conditions 3,4 . Type 2 diabetes mellitus is characterized by an accumulation of advanced glycation end-products (AGEs) in the ECM; however, how this affects HCC in non-cirrhotic conditions is unclear. Here we find that, in patients and animal models, AGEs promote changes in collagen architecture and enhance ECM viscoelasticity, with greater viscous dissipation and faster stress relaxation, but not changes in stiffness. High AGEs and viscoelasticity combined with oncogenic β-catenin signalling promote HCC induction, whereas inhibiting AGE production, reconstituting the AGE clearance receptor AGER1 or breaking AGE-mediated collagen cross-links reduces viscoelasticity and HCC growth. Matrix analysis and computational modelling demonstrate that lower interconnectivity of AGE-bundled collagen matrix, marked by shorter fibre length and greater heterogeneity, enhances viscoelasticity. Mechanistically, animal studies and 3D cell cultures show that enhanced viscoelasticity promotes HCC cell proliferation and invasion through an integrin-β1–tensin-1–YAP mechanotransductive pathway. These results reveal that AGE-mediated structural changes enhance ECM viscoelasticity, and that viscoelasticity can promote cancer progression in vivo, independent of stiffness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06991-9

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 61 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [43]Jones, M. G. et al. Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis. eLife7, e36354 (2018). PMC6029847 29966587

Cited by

Sorted by citations

Authors
Fan, W., Adebowale, K., Váncza, L., Li, Y., Rabbi, M. F., Kunimoto, K., Chen, D., Mozes, G., Chiu, D. K.-C., Li, Y., Tao, J., Wei, Y., Adeniji, N., Brunsing, R. L., Dhanasekaran, R., Singhi, A., Geller, D., Lo, S. H., Hodgson, L., Engleman, E. G., Charville, G. W., Charu, V., Monga, S. P., Kim, T., Wells, R. G., Chaudhuri, O., & Török, N. J.
Affiliations
  • VA Palo Alto Health Care System (US)
  • Stanford University (US)
  • Purdue University West Lafayette (US)
  • Stanford Medicine (US)
  • University of Pittsburgh (US)
  • University of California, Davis (US)
  • Albert Einstein College of Medicine (US)
  • Keio University (JP)
  • University of Pennsylvania (US)
Venue
Nature
Published
2024-01-31
Volume
626
Issue
7999
Pages
635-642
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4391383681
Cited by
263
References
61
Citations by year
2026: 96 · 2025: 117 · 2024: 49 · 2023: 1
FWCI
58.91
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Science Foundation (2026822)
  • U.S. Department of Veterans Affairs (I01 BX002418)
  • Stanford Diabetes Research Center (P30DK116074)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (26822)
  • National Institutes of Health (/ NIDDK R01, ECCS-2026822, S10RR02557401, 1s10od032300-01, 1s10od010580-01a1, 1RO1AG060726)
  • National Institute on Aging (R01AG060726)
  • National Cancer Institute (R01CA204586, R01CA251155, R37CA214136, P30CA124435, R01CA277710, R01CA250227)
  • National Institute of General Medical Sciences (R01GM126256, R35GM136226)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK083283, P30DK120531, P30DK116074, R01DK062277)
  • National Center for Research Resources (1S10OD010580-01A1, S10RR02557401, 1S10OD010580)
  • Division of Electrical, Communications and Cyber Systems (ECCS-2026822, 2026822)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Physical Sciences › Engineering › Biomedical Engineering › Elasticity and Material Modeling
Keywords
hepatocellular carcinoma, advanced glycation end products, type 2 diabetes, collagen structure, extracellular matrix stiffness, β-catenin signaling, collagen cross-links, beta1 integrin, YAP, mechanotransduction, cancer cell proliferation and invasion
MeSH terms
Receptor for Advanced Glycation End Products, Tensins, YAP-Signaling Proteins, Animals, Collagen, Computer Simulation, Diabetes Mellitus, Type 2, Elasticity, Extracellular Matrix, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Neoplasm Invasiveness, Viscosity, Glycation End Products, Advanced, Disease Progression, Integrin beta1, Cell Proliferation, beta Catenin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review